Clinical Trials Logo

Vascular Depression clinical trials

View clinical trials related to Vascular Depression.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT01974934 Recruiting - Vascular Depression Clinical Trials

Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression

Start date: December 2013
Phase: Phase 4
Study type: Interventional

To examine the efficacy and safety of treatment with desvenlafaxine for vascular depression. Primary efficacy, as it pertains to depressive symptoms, will be assessed by overall change in symptom severity score from baseline to 12-weeks, measured by the Geriatric Depression Scale. The primary efficacy measure of cognition will be the Montreal Cognitive Assessment and analysis of change between baseline and 12-week scores. To evaluate the effectiveness of desvenlafaxine as a first-line treatment for vascular depression in a sub-group of patients who have experienced a TIA greater than 6 weeks prior to baseline. Mean differences between baseline and 12-week efficacy measures will be examined within the sub-group.